Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darou Darman Pars is a prominent Iranian pharmaceutical company specializing in the registration, importation, and distribution of specialized and high-tech medicinal products. Founded in 2004, the company focuses on critical therapeutic areas including oncology, hematology, nephrology, and rare diseases. It acts as a strategic partner for several international pharmaceutical manufacturers, facilitating the availability of advanced therapies in the Iranian healthcare market. The company maintains a robust distribution network and adheres to international quality standards to ensure the safe delivery of life-saving medications. Its operations are centered in Tehran, where it manages regulatory affairs and logistics for a diverse portfolio of imported pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darou Darman Pars.